Scientists put 'names to faces' as they finally match genetic risk factors for Inflammatory Bowel Disease to genes and cells.
The post Scientists ID First Inflammatory Bowel Disease Genetic Markers Linked to the Gut appeared first on Medical News Bulletin.
Each week, thousands of wellness studies hit the news, but most of them are very scientific and complicated for the ordinary person to understand. The problem isn’t in finding information—it’s in translating it to people without distorting the meaning. Storytelling based on science is the key tool for positioning creators, health coaches, and wellness brands […]
The post How to Translate Complex Wellness and Lifestyle Research Into Engaging Social Media Content appeared first on Medical News Bulletin.
Sleep optimization has become a holy grail in the biohacking community. From experimenting with different supplements to tracking REM cylces, modern wellness enthusiasts are obsessed with squeezing every drop of restorative benefits from their night rest. Among the more interesting compounds that gain attention in Delta Sleep-inducing peptide, or DSIP, is a naturally occurring peptide […]
The post Deep Sleep Inducing Peptide(DSIP) & Sleep Architecture: How Biohackers Interpret “Deep Sleep” Claims? appeared first on Medical News Bulletin.
Patient enrollment delays rarely happen because investigators can’t find participants. More often, they occur because operational processes such as: take longer than expected. These operational processes can further slow enrollment and push key study milestones off schedule. They also turn into bottlenecks, which leads to: Modern clinical trial supply management software often includes Randomization and […]
The post How Randomized and Trial Supply Management (RTSM) Supports Faster Patient Enrollment and Randomization appeared first on Medical News Bulletin.
Indefinite lenalidomide maintenance therapy does not significantly improve survival compared with a 2-year regimen for patients with standard-risk myeloma.
Results of a randomized phase 3 trial also showed individuals who received continuous therapy experienced significantly more toxicities, including a higher rate of second primary malignancies.
“The clinical trial clearly demonstrated that giving lenalidomide for 2 years is sufficient for patients with standard-risk multiple myeloma,” Shaji Kumar, MD, research chair for the division of hematology at Mayo Clinic, told Healio.
Treatment
Federal officials said this week that the United States will release $600 million in held-up funding to Gavi, the Vaccine Alliance — another sign the relationship between the current administration and the vaccine distributor has warmed.
HHS Secretary Robert F. Kennedy Jr. had pulled U.S. funding for Gavi in 2025, saying the alliance, which provides immunizations for half of the world’s children, ignored vaccine safety concerns, a claim experts have disputed.
But in June of this year, as an outbreak of Ebola unfolded in central Africa, Secretary of State Marco Rubio told senators that the U.S.
A one-time injection of ABBV-RGX-314, a gene therapy for wet age-related macular degeneration, yielded reductions in treatment burden and strong visual acuity maintenance at 5 years with no new safety signals, according to a speaker.
At the American Society of Retina Specialists annual meeting, Robert L. Avery, MD, of California Retina Consultants, presented long-term follow-up data on the RGX-314-001 phase 1/2a study that looked at five dosing levels of ABBV-RGX-314 (sura-vec, Regenxbio, AbbVie) in 37 patients who were enrolled into five cohorts. The primary endpoint was safety assessments
Progression to more severe levels of glaucoma was significantly linked to increased burden of systemic comorbidities, according to a study published in Journal of Glaucoma.
“Glaucoma requires early detection and consistent treatment adherence to prevent vision loss,” Melody Y. Zhou, a medical student at Case Western Reserve University School of Medicine, and colleagues wrote. “Comorbidities can contribute to lower medication adherence due to competing health priorities, functional limitations and the complexities of managing multiple medications.”
To learn more about
Up to 21.5 million additional U.S. adults may be considered eligible for statin therapy based on newly updated dyslipidemia guideline, largely due to risk reclassification using the updated PREVENT-ASCVD equations, researchers reported.
As Healio previously reported, the American Heart Association and American College of Cardiology issued an updated guideline for treatment of dyslipidemia and prevention of atherosclerotic CVD, with an emphasis on health-related behaviors and early initiation of lipid-lowering therapies. The guideline also emphasized use of the PREVENT-ASCVD equations to assess
Nearly one-third of Americans intentionally tan outdoors, according to data from a National Health Interview Survey published in JAMA Dermatology.
Of those who reported experiencing sunburn in the 2024 survey, 49.9% intentionally tanned outdoors vs. 28.3% who did not — a nearly twofold difference, according to Dawn M. Holman, MPH, behavioral scientist in the division of cancer prevention and control at the National Center for Chronic Disease Prevention and Health Promotion.
“Intentional outdoor tanning is a deliberate but preventable way that people increase their exposure to ultraviolet